超声引导下经皮冷冻神经松解术治疗痉挛的疗效观察
本研究为回顾性病历分析,纳入22例在门诊神经康复诊所接受超声引导下经皮冷冻神经松解术的痉挛患者。结果显示MAS评分从基线中位数3(IQR 2)显著改善至随访时1+(IQR 1;W=7,P<0.05),94%患者报告功能主观改善,81%报告疼痛缓解,32%出现副作用。提示该技术可能作为难治性痉挛的辅助或替代治疗。
要点
- 超声引导下冷冻神经松解术后MAS评分显著改善,中位随访4.36个月。
- 94%患者报告功能改善,81%报告疼痛缓解,32%出现副作用。
- 该技术为微创,可能作为难治性痉挛的辅助或替代治疗。
核心结论
- 超声引导下经皮冷冻神经松解术可能是治疗痉挛的有前景的微创方法,可作为难治性痉挛的辅助或替代治疗。
研究设计与样本
- 回顾性病历分析,纳入22例在门诊神经康复诊所接受超声引导下经皮冷冻神经松解术的痉挛患者,所有患者先接受诊断性利多卡因注射,随后对上肢和/或下肢神经进行冷冻神经松解。
主要发现
- MAS数据(n=19)显示从基线中位数3(IQR 2)显著改善至随访时1+(IQR 1;W=7,P<0.05),平均随访4.36个月。
- 94%(n=18)患者报告主观功能改善,81%(n=16)报告疼痛缓解。
- 32%患者报告副作用,包括疼痛、感觉异常和无力。
关键数值与推荐
- MAS评分从基线中位数3(IQR 2)改善至随访1+(IQR 1),W=7,P<0.05。
- 主观功能改善报告率94%(n=18),疼痛缓解报告率81%(n=16),副作用报告率32%。
临床怎么用
- 对于难治性痉挛患者,可考虑超声引导下经皮冷冻神经松解术作为辅助或替代治疗选项。
- 治疗前应进行诊断性利多卡因注射以确认靶神经。
- 需告知患者可能出现疼痛、感觉异常和无力等副作用。
局限性
- 本研究为回顾性病历分析,样本量小(n=22),无对照组。
- 随访时间平均4.36个月,缺乏长期疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Spasticity is a manifestation of upper motor neuron disease which often impacts function, pain, and quality of life. Given the limited treatment modalities, exploring new interventions for spasticity management is imperative. This retrospective chart review study aims to review outcomes following ultrasound-guided percutaneous cryoneurolysis for the treatment of spasticity in patients in an outpatient neurorehabilitation clinic. All patients (n=22) underwent diagnostic lidocaine injection followed by cryoneurolysis of upper and/or lower extremity nerves. Outcomes included Modified Ashworth Scale (MAS) scores at baseline and >3 months post-procedure (average follow-up of 4.36 mo after cryoneurolysis), and patient-reported changes in function, pain, and side effects >3 months after cryoneurolysis. MAS data (n=19) showed statistically significant improvement from a median baseline of 3 (IQR 2) to follow-up of 1+ (IQR 1; W=7, P<0.05). Subjective functional improvements (Figure 2) were reported in 94% (n=18) of patients and pain relief was noted in 81% (n=16). Side effects were reported in 32% of patients and included pain, dysesthesias, and weakness. Ultrasound-guided cryoneurolysis appears to be a promising, minimally invasive treatment for spasticity and may serve as a useful adjunct or alternative for refractory spasticity.
引用
- Piasecki-Masters C, Germain NS, Struck K, et al. Outcomes Following Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Spasticity. Am J Phys Med Rehabil. 2026. PMID: 42296449. doi:10.1097/PHM.0000000000003054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。